Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso

Annals of African Medicine

Volumn 9, Issue 1, 2010, Pages 15-19

  Sangare L ^a,b   Diande S ^b,c   Kouanda, S ^b   Dingtoumda, B ^b   Mourfou, A ^b   Ouedraogo F ^b   Sawadogo, I ^b   Nebie B ^b   Gueye, A ^b   Sawadogo, L T ^c   Traore A S ^b  

^a University Hospital Yalgado Ouedraogo   (Burkina Faso)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c National Centre Against Tuberculosis   (Burkina Faso)

Author keywords

Burkina faso; Drug resistance; Ouagadougou; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKINA FASO; CONTROLLED STUDY; DRUG SCREENING; DRUG SENSITIVITY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RELAPSE; SAMPLING; SPUTUM; TREATMENT FAILURE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTITUBERCULAR AGENTS; BURKINA FASO; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77952088843     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.62619     Document Type: Article

References (23)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367:938-40.
2. Center for Disease Control. Primary resistance to antituberculosis drugs, United States. MMWR Morb Mortal Wkly Rep 1983;32:521-3.
3. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drugresistant tuberculosis in New York City. N Engl J Med 1993;328:521-32. (Pubitemid 23053827)
4. Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-71. (Pubitemid 24061700)
5. Grosset J. Fréquence et gravité actuelles de la résistance de Mycobacterium tuberculosis aux antibiotiques. Ann Inst Pasteur 1993;4:196-202. (Pubitemid 23330860)
6. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1994-1997. Antituberculosis drug resistance in the world. Geneva: WHO Tuberculosis Global Programme, 1997.
7. WHO/IUATLD. Anti-tuberculosis drug resistance in the world: Third global report/the WHO/IUATLD Global Project on anti-tuberculosis drug resistance surveillance 1999-2002.
8. Dosso M, Bonard D, Msellati P, Bamba A, Doulhourou C, Vincent V, et al. Primary resistance to antituberculosis drugs: A national survey conducted in Côte d'Ivoire. Int J Tuber Lung Dis 1999;3:805-9. (Pubitemid 29425951)
9. Kuaban C, Bercion R, Jifon G, Cunin P, Blackett KN. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis 2000;4:427-32. (Pubitemid 30256845)
10. Warndorff DK, Yates M, Ngwira B, Chagaluka S, Jenkins PA, Drobniewski F, et al. Trends in antituberculosis drug resistance in Karonga, Malawi, 1986-1998. Int J Tuber Lung Dis 2000;4:752-7.
11. Demissie M, Gebeyehu M, Berhane Y. Primary resistance to antituberculosis drugs in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis 1997;1:64-7. (Pubitemid 127509688)
12. Owusu-Dabo E, Adjei O, Meyer CG, Horstmann RD, Enimil A, Kruppa TF, et al. Mycobacterium tuberculosis drug resistance, Ghana. Emerg Inf Dis 2006;12:1171-2. (Pubitemid 44061301)
13. Ledru S, Cauchoix B, Yaméogo M, Zoubga A, Lamandé-Chiron J, Portaels F, et al. Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso. Tuberc Lung Dis 1996;77:429-36. (Pubitemid 26390471)
14. Enarson DA, Rieder HL, Arnadottir T. Managements of tuberculosis: Guide for low income countries. 5th ed. Paris: WHO/IUATLD; 2000.
15. Petroff SA. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med 1915;21:38-42.
16. Keilty RA. A fnal report on the cultivation of the tubercle bacillus from the sputum by the method of Petroff. J Exp Med 1916;24:41-8.
17. El Helali N, Vergez P. Identifcation des mycobactéries. Feuillets de Biologie 1993;34:5-19.
18. Canetti G, Rist N, Grosset J. Mesure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Rev Tuberc Pneumol 1963;27:217-72.
19. Kouassi B, Horo K, N'douba KA, Koffi N, Ngom A, Aka-Danguy E, et al. Profil épidémiologique et microbiologique des malades tuberculeux en situation d'échec ou de rechute aæ Abidjan. Bull Soc Exot 2004;97:336-7. (Pubitemid 40409489)
20. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbial 2004;53:107-13. (Pubitemid 38223688)
21. Saribas S. Resistance problems in Mycobacterium tuberculosis: Evaluation of the resistance of 166 M. tuberculosis strains against four major drugs. Euro Soc Clin Microbiol Infect Dis 2004; 902: n1287.
22. Quy HT, Lan NT, Borgdorff MW, Grosset J, Linh PD, Tung LB, et al. Drug resistance among failure and relapse cases of tuberculosis: Is the standard re-treatment regimen adequate? In J Tuberc Lung Dis 2003;7:631-6. (Pubitemid 36806857)
23. Senneville E. Traitement des patients porteurs de souches résistantes. Med Mal Infect 1995;25:369-76.